Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

Part of paid clinical trials in Tucson, Arizona.

Sponsor
Chiron Corporation
Study ID
NCT00045864
Phase
PHASE2
Status
Completed

Conditions

  • Lymphoma, Non-Hodgkin

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with intermediate-and high- grade Non-Hodgkin's lymphoma.

Key Dates

Status verified
Feb 2006

Study Design

Primary purpose
TREATMENT

Locations (33)

FacilityCityStateZIPSite coordinators
ACRC/Arizona Clinical Research Center, Inc.TucsonArizona85712-
Hoag Cancer CenterNewport BeachCalifornia92658-
UC Davis Cancer CenterSacramentoCalifornia95817-
John Wayne Cancer InstituteSanta MonicaCalifornia90404-
Stanford University Medical CenterStanfordCalifornia94305-5151-
California Cancer Medical CenterWest CovinaCalifornia91790-
Georgetown University Medical Center, Lombardi Cancer CenterWashington D.C.District of Columbia20007-
Washington Cancer InstituteWashington D.C.District of Columbia20010-
Division of Hematology/Oncology, University of Miami School of MedicineMiamiFlorida333136-
Northwestern University, Feinberg School of MedicineChicagoIllinois60611-
Rush Cancer InstituteChicagoIllinois60612-
Oncology Specialists, S.C.Park RidgeIllinois60068-
Cancer Care CenterBloomingtonIndiana47403-
Consultants in Blood Disorders and CancerLouisvilleKentucky40207-
Louisiana Health Sciences Center, Department of Medicine, Hematology/OncologyShreveportLouisiana71130-
Kansas City Oncology and Hematology GroupKansas CityMissouri64111-
Arch Medical Group, LLCSt LouisMissouri63141-
Dartmouth-Hitchcock-Medical CenterLebanonNew Hampshire03756-
Memorial Sloan Kettering Cancer CenterNew YorkNew York10021-
Our Lady of Mercy Medical Center, Comprehensive Cancer CenterThe BronxNew York10466-
East Carolina University School of Medicine/ Division of Hematology/OncologyGreenvilleNorth Carolina27858-
Roger Maris Health SystemFargoNorth Dakota58122-
Gabrail Cancer CenterCantonOhio44718-
Oncology Hematology Care Inc.CincinnatiOhio45242-
The Cleveland Clinic FoundationClevelandOhio44195-
Hematology /Oncology Consultants Inc.ColumbusOhio43235-
Oregon Heath and Science UniversityPortlandOregon97201-
University of PennsylvaniaPhiladelphiaPennsylvania19104-
Cancer Centers of the CarolinasGreenvilleSouth Carolina29615-
Germantown Cancer CenterGermantownTennessee38138-
Vanderbilt University Medical CenterNashvilleTennessee37232-
Cancer Specialists of South Texas, P.A.Corpus ChristiTexas78412-
Virginia Cancer InstituteRichmondVirginia23230-

Find similar trials in Tucson, AZ

By research site
ACRC/Arizona Clinical Research Center, Inc.· Tucson, AZHoag Cancer Center· Newport Beach, CAUC Davis Cancer Center· Sacramento, CAJohn Wayne Cancer Institute· Santa Monica, CAStanford University Medical Center· Stanford, CACalifornia Cancer Medical Center· West Covina, CA

Related Studies